People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Other, Biotechnology, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Float Financial, LLC | — | Other | Series A | $9.8M | $10.8M | 2021 |
| Cessation Therapeutics, Inc. | — | Biotechnology | Series A | $6.8M | $5.9M | 2024 |
| Glass U, LLC | — | Retailing | Seed | $3.3M | $6.3M | 2014 |
Daniel Fine at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Fine on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Genecov | 1 | 4 |
| Sharon Tetlow | 1 | 4 |
| John Harkey | 1 | 3 |
| Jay Shepard | 1 | 3 |
| Pericles Mazarakis | 1 | 2 |
| Eric Rasmussen | 1 | 2 |
| Deborah Fine | 1 | 1 |
| Andrew Barrett | 1 | 1 |
| Mark Pearson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.